Search research articles
Contact Us
Filters
Showing results (301-310 of 334) with videos related to
Page
of 34
Sort By:
Kidney International
|
August 1, 1996
Relationship of dose of hemodialysis and cause-specific mortality
W E Bloembergen, D C Stannard, F K Port, et al.
Veterinary Parasitology
|
May 20, 2009
The role of targeted selective treatments in the development of refugia-based approaches to the control of gastrointestinal nematodes of small ruminants
F Kenyon, A W Greer, G C Coles, et al.
FEMS Microbiology Ecology
|
April 5, 2022
Microbial community response to simulated diluted bitumen spills in coastal seawater and implications for oil spill response
Susan E Cobanli, Gary Wohlgeschaffen, Camilla Ryther, et al.
Frontiers in Microbiology
|
March 17, 2020
Metatranscriptomic Insights Into the Response of River Biofilm Communities to Ionic and Nano-Zinc Oxide Exposures
Jordyn Bergsveinson, Julie Roy, Christine Maynard, et al.
FEMS Microbiology Ecology
|
June 14, 2021
In situ microcosms deployed at the coast of British Columbia (Canada) to study dilbit weathering and associated microbial communities under marine conditions
Lars Schreiber, Nathalie Fortin, Julien Tremblay, et al.
The American Journal of Pathology
|
March 1, 1995
Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease
S R Zaki, P W Greer, L M Coffield, et al.
Kidney International
|
May 1, 1993
Early dosing practices and effectiveness of recombinant human erythropoietin
N R Powe, R I Griffiths, J W Greer, et al.
Applied and Environmental Microbiology
|
May 26, 2001
Selection of specific endophytic bacterial genotypes by plants in response to soil contamination
S D Siciliano, N Fortin, A Mihoc, et al.
JAMA
|
September 16, 1992
Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval
N R Powe, R I Griffiths, G de Lissovoy, et al.
Medical Care
|
February 1, 1994
The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients
G de Lissovoy, N R Powe, R I Griffiths, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 334) with videos related to
Sort By:
Page
of 34
Kidney International
|
August 1, 1996
Relationship of dose of hemodialysis and cause-specific mortality
W E Bloembergen, D C Stannard, F K Port, et al.
Veterinary Parasitology
|
May 20, 2009
The role of targeted selective treatments in the development of refugia-based approaches to the control of gastrointestinal nematodes of small ruminants
F Kenyon, A W Greer, G C Coles, et al.
FEMS Microbiology Ecology
|
April 5, 2022
Microbial community response to simulated diluted bitumen spills in coastal seawater and implications for oil spill response
Susan E Cobanli, Gary Wohlgeschaffen, Camilla Ryther, et al.
Frontiers in Microbiology
|
March 17, 2020
Metatranscriptomic Insights Into the Response of River Biofilm Communities to Ionic and Nano-Zinc Oxide Exposures
Jordyn Bergsveinson, Julie Roy, Christine Maynard, et al.
FEMS Microbiology Ecology
|
June 14, 2021
In situ microcosms deployed at the coast of British Columbia (Canada) to study dilbit weathering and associated microbial communities under marine conditions
Lars Schreiber, Nathalie Fortin, Julien Tremblay, et al.
The American Journal of Pathology
|
March 1, 1995
Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease
S R Zaki, P W Greer, L M Coffield, et al.
Kidney International
|
May 1, 1993
Early dosing practices and effectiveness of recombinant human erythropoietin
N R Powe, R I Griffiths, J W Greer, et al.
Applied and Environmental Microbiology
|
May 26, 2001
Selection of specific endophytic bacterial genotypes by plants in response to soil contamination
S D Siciliano, N Fortin, A Mihoc, et al.
JAMA
|
September 16, 1992
Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval
N R Powe, R I Griffiths, G de Lissovoy, et al.
Medical Care
|
February 1, 1994
The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients
G de Lissovoy, N R Powe, R I Griffiths, et al.
Page
of 34